The worldwide cell therapy market was estimated to be worth of US$ 6,876.8 Mn in 2021 and is projected to grow at a CAGR of 6.9% between 2022 and 2028 to reach US$ 10,944.3 Mn. Because of the rising incidence of chronic diseases as well as expanding use of the expanding use of regenerative medicines around the world, the global market for cell therapy is expanding rapidly. Additionally, a greater emphasis on the advancement of cell therapies for the management of straightforward or difficult medical problems is anticipated to fuel market expansion. The cell treatment industry is likely to experience a slow growth, nonetheless, due to the factors like the increased cost of cell therapies and the poor reimbursement environment.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5413
Global Cell Therapy Market: Regional Insights
The worlwide cell therapy market is divided into five geographic regions: North America, Africa, Middle East, Asia Pacific, Europe, & Latin America.
Because chronic diseases are becoming more common there and there are greater clinical trials for cell-based therapies there, North America is projected to gain the largest market share during the projection period. For example, hematopoietic stem cell transplantation is the most popular cell therapy for the treatment of hematologic diseases and blood cancers. Hematopoietic (or blood) stem cell transplantation is the only stem cell-based therapy that has undergone FDA assessment and been given the all-clear. Cancer patients and those with immune system and blood disorders are treated with it.
The reason for increased incidence of cancer, increasing use of regenerative medicine, and support from governments in this area, Asia Pacific is also anticipated to experience rapid expansion in the worldwide cell therapy market. For example, cell-based therapies seek to increase the body’s immune system’s capacity to battle against cancer. The number of cancer patients in India is predicted to rise from 26.7 million in 2021 to 29.8 million in year 2025, according to the Indian Council for Medical Research. Breast, lung, cervix uteri cancers, mouth, stomach, liver, and oesophagus, as well as other 7 cancers, registered for over 40% of the overall burden of disease.
Global Cell Therapy Market Drivers:
Over the course of the projected period, it is anticipated that the incidence of chronic diseases would rise globally. Examples of diseases that can be treated with cell-based therapies include cancer, autoimmune diseases, infectious diseases, urinary problems, and neurological disorders. The primary reason of disability and death worldwide, as per the WHO, are chronic diseases. Roughly 10 million deaths, or nearly 1 in 6 deaths, were caused by cancer in 2020, making it one of the major causes of mortality worldwide. Consequently, there is a rise in requirement for cell-based therapies on a global scale.
The worldwide cell therapy market is anticipated to grow at a faster rate than average during the projected period due to rising regenerative medicine usage. The market for cell treatment on a global scale is very cutthroat. This is explained by the increase in therapeutic uses for cell therapies which has led the market players concentrating on introducing new products.
Global Cell Therapy Market Opportunities:
Significant potential prospects for participants in the worldwide cell therapy market are anticipated to result from the increased development of innovative medicines for the treatment of easy to complex medicinal diseases. For illustration, in order to concentrate its induced pluripotent stem cell (iPSC) expertise on the development and manufacture of cell therapies, Ncardia established a separate company, Cellistic, in April 2022. This strategy builds on Ncardia’s already-existing drug discovery solutions business and takes advantage of the firm’s extensive expertise in iPSC differentiate it and expansion to concentrate committed capabilities and resources to satisfy the expanding demand for iPSC cell therapy solutions.
For companies in the worldwide cell therapy market, the growing number of clinical studies is anticipated to present substantial potential prospects. For example, in January 2020, Allogene Therapeutics, Inc. and SpringWorks Therapeutics, Inc. agreed to collaborate on a clinical trial to test ALLO-715, Allogene Therapeutics’ experimental drug anti-B-cell maturation antigen (BCMA) AlloCAR T therapy, in combined effect with SpringWorks Therapeutics’ investigational gamma secretase inhibitor (GSI), Nirogacestat, in patients with relapsed/refractory multiple myelom The global market for cell treatment is then anticipated to develop as a result.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5413
Global Cell Therapy Market Trends:
Pharmaceutical companies working on the research and development (R&D) of cutting-edge medicines to address a wide range of medical ailments have identified cell therapy as their next growth area. To research regulatory T-cell (Treg) therapeutics for autoimmune illnesses, for instance, Sonoma Biotech and Kyverna Therapeutics partnered together in 2020. The market expansion will be fueled by this trend, which is anticipated to last throughout the projected period.
The interest for cell-based therapies from around world has risen or is growing as a result of factors like as the growing propensity of physicians toward the rise in awareness of the therapies and the therapeutic use of cell therapies across a variety of therapeutic fields. Over the projection period, it is anticipated that this pattern will continue, fueling the expansion of the cell therapy market.
Global Cell Therapy Market Restraints:
The expansion of the worldwide cell therapy market is anticipated to be constrained by the high cost of cell therapies. For illustration, the average cost per therapy for Kite Pharma/Yescarta Gilead’s and Novartis’ Kymriah is approximately US$ 475,000 and US$ 373,000, respectively. The only CAR-T cell therapy with FDA approval is Kymriah, while the only therapy with EC approval is Yescarta. Depending on the type of transplant, such as an allogenic transplant or an autologous transplant, the price of receiving stem cell therapy in India can range from Rs. 15 lakhs to Rs. 25 lakhs.
The market for cell treatment is predicted to grow slowly due to the poor reimbursement environment. For instance, individual biotechnology and pharmaceutical businesses in the U.S. face significant reimbursement issues for cellular therapies in the near future.
Global Cell Therapy Market Segmentation:
The market report for cell therapy is divided into Type, Therapy, Application, and Geography.
Based on Type, both autologous and allogeneic cell therapies are sold on the international market. Due to the rising use of autologous cell therapy (ACT), the autologous segment is anticipated to gain a foothold in the cell therapy market over the projected period. People who require significant doses of chemotherapy and radiation to treat their conditions frequently use autologous stem cell transplants.
Based on Therapy, the market is divided into fibroblast cell therapy, hematopoietic stem cell therapy, mesenchymal stem cell therapy, as well as other therapies. Due to the expanding therapeutic application of MSC therapies, the mesenchymal stem cell therapy segment is likely to dominate the market over the projected period. Several therapeutic issues, including immune system regulation, may be handled by mesenchymal stem cells (MSCs).
Fibroblast Cell Therapy Segment because of the increasing use of fibroblast cell treatment in aesthetics, is also predicted to have substantial increase in the near future.
Based on Application, Dermatology, Malignancies, Cardiovascular and Wounds, and Other Applications are the different market segments for cell therapy. Which is why the musculoskeletal segment is projected to rule the market over the course of the next coming period. This is because there are more incidences of musculoskeletal ailments than ever before. Many types of pain connected to musculoskeletal system are already being treated using stem cell therapy.
Malignancies Segment is also anticipated to experience significant growth in the near future, and these is because cancer is becoming more common in the world.
Global Cell Therapy Market: Key Developments
In August 2020, Novartis AG stated that Novartis Kesimpta, a targeted B-Cell treatment for relapse multiple sclerosis, has been approved by the U. S. Food and Drug Administration (FDA).
In June 2020, the production facility for CAR T-cell therapy in Europe has been given European Medicine Agency approval, according to Kite Pharma Inc.
In March 2019, in order to spread awareness of the potential advantage of fibroblast and to provide a development knowledge base for the exciting field of regenerative medicine, SpinalCyte LLC has developed a new comprehensive resources.
Global Cell Therapy Market: Key Companies Insights
The market for cell treatment on a worldwide scale is very cutthroat. This is explained by the increase in therapeutic uses for cell-based therapies, which has led to market players concentrating on introducing new product.
Major players in the worlwide cell therapy market are Gilead Sciences Inc. (Kite Pharma Inc.), Takeda Pharmaceutical Company Limited (TiGenix), Allogene Therapeutics Inc., Vericel Corporation, Novartis AG, Organogenesis Inc., Dendreon Pharmaceuticals LLC, Nipro Corporation, Medipost Co. Ltd., Stempeutics Research Pvt. Ltd., among others.
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5413
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Cell Therapy Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Cell Therapy Industry Impact
Chapter 2 Global Cell Therapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global Cell Therapy (Volume and Value) by Type
2.3 Global Cell Therapy (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Cell Therapy Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Cell Therapy Market Analysis
Chapter 6 East Asia Cell Therapy Market Analysis
Chapter 7 Europe Cell Therapy Market Analysis
Chapter 8 South Asia Cell Therapy Market Analysis
Chapter 9 Southeast Asia Cell Therapy Market Analysis
Chapter 10 Middle East Cell Therapy Market Analysis
Chapter 11 Africa Cell Therapy Market Analysis
Chapter 12 Oceania Cell Therapy Market Analysis
Chapter 13 South America Cell Therapy Market Analysis
Chapter 14 Company Profiles and Key Figures in Cell Therapy Business
Chapter 15 Global Cell Therapy Market Forecast (2023-2030)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027